MB3057 Antimicrobial drug resistance a global threat 1 - Oggioni
Page 1: Overview of Antimicrobial Drug Resistance
Title: MB3057 Antimicrobial drug resistance: a global threat
Presenter: Marco R. Oggioni, Department of Genetics and Genome Biology, University of Leicester
Page 2: Drug Targets and Resistance
Drug Target Characteristics:
Selective for bacterial cells.
Essential for bacterial replication and survival.
Mechanisms common to most bacterial cells (broad spectrum).
Resistance Factors:
Drug resistance reduces the activity spectrum (narrow spectrum).
Antimicrobial drug use selects for drug resistance.
Types of Antimicrobial Agents:
Antibiotics (e.g., penicillin): high selectivity, systemic use.
Antiseptics (e.g., chlorhexidine): reasonable selectivity, topical use.
Disinfectants (e.g., sodium hypochlorite): low selectivity, environmental use.
Key Points:
Most agents target bacteria; fewer target fungi, viruses, protozoa, and helminths.
Clinical antimicrobial agents do not affect bacterial spores, fungi spores, or latent viruses.
Major Groups:
β-lactam compounds (e.g., penicillins, cephalosporins): semisynthetic derivatives with varied properties.
Other antibacterial agents: aminoglycosides, tetracyclines, macrolides, glycopeptides, quinolones.
Page 3: Phylogenetic Tree of Cellular Life
Domains of Life:
Bacteria, Archaea, Eucarya.
Classification Examples:
Examples of specific organisms across the spectrum of life, such as:
Green nonsulfur bacteria
Methanosarcina (Archaea)
Eucarya examples like animals and plants.
Page 4 & 5: Antibacterial Targets - Macromolecular Structures
Macromolecular Structures:
Targets include ribosomes (30S and 50S), RNA polymerase, or DNA gyrase.
Antibacterial Agents:
Examples with specific targets:
Tetracycline (30S)
Penicillin (cell wall)
Rifampicin (RNA polymerase)
Ciprofloxacin (DNA gyrase).
Page 6: Principal Types of Antibacterial Agents
Focus on antibacterial agents excluding those for mycobacterial infections.
Page 7: Clinical Activity Overview
Agents and Their Clinical Activity Against Bacteria:
Detailed activity against various bacterial strains:
Penicillins: Cell wall agents effective against multiple bacteria.
Cephalosporins: Effective against similar bacteria to penicillins.
Tetracyclines: Ribosome-targeting agents effective against a variety.
Other specific agents listed with their spectrum of activity.
Page 8: Inhibitors of Cell Wall Synthesis
Mechanism of Action:
Glycopeptides such as vancomycin are effective against Gram-positive organisms with multiple resistances.
Page 9: Molecular Structures of β-Lactam Antibiotics
Examples:
Various penicillins like ampicillin and cephalosporins like cefuroxime.
Characteristics and resistance abilities of some agents highlighted.
Page 10: Penicillin Allergies
Allergy Overview:
Significant proportion of anaphylaxis deaths related to penicillin.
Testing and cross-reactivity information.
Page 11: Protein Synthesis Inhibitors
Overview of various inhibitors affecting ribosomal activity including:
Tetracyclines: Broad-spectrum agents.
Chloramphenicol: Broad antibacterial spectrum but with serious side effects.
Aminoglycosides: Risk of toxicity highlighted.
Macrolides: Effective against specific bacterial infections.
Page 12: Inhibitors of Nucleic Acid Synthesis
Classes of Inhibitors:
Sulphonamides & Diaminopyrimidines: Block folic acid biosynthesis.
Quinolones: Target DNA gyrase, often used for urinary tract infections.
Page 13: Cell Membrane Disruption
Mechanisms:
Polymyxins: Disrupt bacterial cell membranes; often used as last resort agents.
Daptomycin: Effective against resistant Gram-positive organisms.
Page 14: Learning Summary - Lecture 1
Key Concepts:
Antimicrobial drugs demonstrate selective bacterial activity.
Drug discovery pipeline is concerningly empty; big pharma has shifted focus.
Page 15: Part 2 - Antimicrobial Drug Discovery
Overview of the continued challenges and focuses in drug discovery.
Page 16: Antibiotic Discovery Timeline
Overview of new antibacterial agents approved from 1983 to 2003.
Page 17: Relevant Classes of Antibiotics
Natural Product-Derived Antibiotics:
Examples include penicillins, cephalosporins, macrolides, etc.
Page 18: Folic Acid Biosynthesis
Comparison of folic acid biosynthesis pathways in humans vs. Neisseria.
Significance of pathway differences for drug targeting.
Page 19: New Antibiotic Discovery
Focus on Darobactin:
Innovations and discoveries related to targeting Gram-negative bacteria.
Page 20: Deep Learning in Antibiotic Discovery
Use of AI to discover new antibacterial compounds.
Highlights successful identification of effective molecules through deep learning.
Page 21: Summary of Deep Learning Studies
Reinforces the successes and future possibilities of AI in discovering novel antibacterial agents.
Page 22: Future Directions in Antibiotic Research
New targets/approaches, screening methods, and the role of bacteriophages.
Emphasis on antimicrobial stewardship and preventive measures.
Page 23: Learning Summary - Lecture 2
Recap of essential points regarding AMR and its implications for therapeutic choices.
The alarming rise of AMR statistics and projections for the future.